Phase I clinical trial of TBI 304H for the treatment of chemotherapy-induced anaemia.
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2015
At a glance
- Drugs TBI 304 (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Therapure Biopharma
- 09 Apr 2015 Status changed from not yet recruiting to recruiting, as reported in an Abzena media release.
- 17 Mar 2015 New trial record
- 11 Mar 2015 US FDA grants approval for the trial to proceed, according to a Therapure Innovations media release.